The design of the long-anticipated project was originally set to be unveiled by the end of 2018, but has been delayed several times—most recently this spring, as the pandemic began to sweep across the United States.
Gov. Eric Holcomb lifted the ban effective Monday, with some caveats, such as making sure that hospitals keep enough personnel and personal protective equipment on hand for COVID-19 patients.
The two technologies are different, but the goal of both is to provide a result within 40 minutes. The researchers say they are working with manufacturers to develop the products, which they hope will retail for $5 or less.
Baricitinib, also known under the brand name Olumiant, is approved in more than 65 countries as a treatment for adults with moderately to severely active rheumatoid arthritis.
State officials declined to provide details on specifically how the hotel is being used—including whether it is a treatment site for homeless individuals—to protect patient privacy.
IUPUI said Monday it is cleaning and sanitizing University Tower to house health care workers, but no plans have been announced locally for temporary field hospitals.
Just like the pandemic that is sweeping the world, news about COVID-19 is developing almost too quickly to comprehend.
Indiana has been undergoing a huge shift in psychiatric care in recent years, but still doesn’t have the resources to deal with patients suffering from ailments ranging from anxiety to schizophrenia.
The grants ranged in size from $6,000 to $14.47 million and covered almost every aspect of medicine from neurology and psychiatry to anesthesiology and emergency care.
The report, issued Monday by researchers at the Fairbanks School of Public Health at IUPUI, is the latest commentary on Indiana’s poor report card on health care.